NCT00490022View on ClinicalTrials.gov

Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Healthy

Interventions

DRUG

Dihydrotestosterone (DHT) gel (0.7%)

DHT gel, 70 mg/day for one month

DRUG

Placebo gel

Placebo gel for one month

Trial Locations (1)

98195

University of Washington, Seattle

Sponsors

Collaborators (1)

ASCEND Therapeutics

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

collaborator

ASCEND Therapeutics

INDUSTRY

lead

University of Washington

OTHER

NCT00490022 - Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3] | Biotech Hunter | Biotech Hunter